BRPI1006114A2 - "macrolídeo antiinflamatório". - Google Patents

"macrolídeo antiinflamatório".

Info

Publication number
BRPI1006114A2
BRPI1006114A2 BRPI1006114A BRPI1006114A BRPI1006114A2 BR PI1006114 A2 BRPI1006114 A2 BR PI1006114A2 BR PI1006114 A BRPI1006114 A BR PI1006114A BR PI1006114 A BRPI1006114 A BR PI1006114A BR PI1006114 A2 BRPI1006114 A2 BR PI1006114A2
Authority
BR
Brazil
Prior art keywords
macrolide
inflammatory
inflammatory macrolide
Prior art date
Application number
BRPI1006114A
Other languages
English (en)
Inventor
Jane Day Caroline
Filic Darko
Kragol Goran
Bruno Douillet Julien
Jane Kindon Leanda
Marusicistuk Zorica
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41698466&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI1006114(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of BRPI1006114A2 publication Critical patent/BRPI1006114A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
BRPI1006114A 2009-01-30 2010-01-28 "macrolídeo antiinflamatório". BRPI1006114A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14860909P 2009-01-30 2009-01-30
PCT/EP2010/050967 WO2010086349A1 (en) 2009-01-30 2010-01-28 Anti-inflammatory macrolide

Publications (1)

Publication Number Publication Date
BRPI1006114A2 true BRPI1006114A2 (pt) 2018-02-06

Family

ID=41698466

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI1006114A BRPI1006114A2 (pt) 2009-01-30 2010-01-28 "macrolídeo antiinflamatório".

Country Status (23)

Country Link
US (1) US8227428B2 (pt)
EP (1) EP2384333B1 (pt)
JP (1) JP5437394B2 (pt)
KR (1) KR20110099791A (pt)
CN (1) CN102378763A (pt)
AR (1) AR075340A1 (pt)
AU (1) AU2010209732B2 (pt)
BR (1) BRPI1006114A2 (pt)
CA (1) CA2748847A1 (pt)
CL (1) CL2011001829A1 (pt)
CO (1) CO6400226A2 (pt)
DO (1) DOP2011000242A (pt)
EA (1) EA201101139A1 (pt)
ES (1) ES2412059T3 (pt)
IL (1) IL213871A0 (pt)
MA (1) MA32997B1 (pt)
MX (1) MX2011008074A (pt)
PE (1) PE20120220A1 (pt)
SG (1) SG172782A1 (pt)
TW (1) TW201038277A (pt)
UY (1) UY32408A (pt)
WO (1) WO2010086349A1 (pt)
ZA (1) ZA201104653B (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070105993A (ko) 2005-01-13 2007-10-31 글락소스미쓰클라인 이스트라지바치키 센타 자그레브 디.오.오. 소염 활성을 갖는 마크로라이드
TW201038277A (en) 2009-01-30 2010-11-01 Glaxosmithkline Zagreb Anti-inflammatory macrolide
WO2011116312A1 (en) * 2010-03-19 2011-09-22 Catabasis Pharmaceuticals, Inc. Fatty acid macrolide derivatives and their uses
WO2011131749A1 (en) * 2010-04-23 2011-10-27 Glaxo Group Limited New 14 and 15 membered macrolides for the treatment of neutrophil dominated inflammatory diseases
JP6116206B2 (ja) * 2012-11-26 2017-04-19 クリニプロ株式会社 吸入用パウダーの製造方法
RU2742417C1 (ru) * 2017-01-13 2021-02-05 Тобиси Фармасьютикал Ко., Лтд. Регулятор активации нейтрофилов

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US525051A (en) 1894-08-28 Adjustable chair
US3725385A (en) 1970-11-02 1973-04-03 Abbott Lab Process for the demethylation of 3-amino macrolides
EP0126344A2 (en) 1983-05-20 1984-11-28 Abbott Laboratories Tripeptide esters of therapeutic agents
EP0292352A3 (fr) * 1987-05-06 1988-12-28 Adir Et Compagnie Nouveaux dérivés macrolides, leur procédé de préparation et les compositions pharmaceutiques les contenant
SI9011409A (en) 1990-07-18 1995-10-31 Pliva Pharm & Chem Works O-methyl azitromycin derivates, methods and intermediates for their preparation and methods for preparation of pharmaceuticals products which comprise them
EP0895999A1 (en) 1997-08-06 1999-02-10 Pfizer Products Inc. C-4" substituted macrolide antibiotics
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
PT1189912E (pt) * 1999-05-18 2008-05-16 Pfizer Prod Inc Novas formas cristalinas de um antibiótico macrólido
HRP20010301A2 (en) 2001-04-27 2001-12-31 Pliva D D New therapeutic indication for azithromycin in the treatment of non-infective inflammatory diseases
NZ537717A (en) 2002-07-08 2006-04-28 Pliva Istrazivacki Inst D New compounds, compositions and methods for treatment of inflammatory diseases and conditions
ITMI20021726A1 (it) 2002-08-01 2004-02-02 Zambon Spa Macrolidi ad attivita' antiinfiammatoria.
GB0310986D0 (en) 2003-05-13 2003-06-18 Glaxo Group Ltd Novel compounds
ES2317527T3 (es) * 2005-01-13 2009-04-16 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Decladinosil-macrolidos que presentan actividad anti-inflamatoria.
KR20070105993A (ko) * 2005-01-13 2007-10-31 글락소스미쓰클라인 이스트라지바치키 센타 자그레브 디.오.오. 소염 활성을 갖는 마크로라이드
ATE523519T1 (de) * 2005-01-14 2011-09-15 Glaxo Group Ltd Makrolidverbindungen mit biotin und fotoaffinitätsgruppe zur identifizierung eines makrolid-targets
TW201038277A (en) 2009-01-30 2010-11-01 Glaxosmithkline Zagreb Anti-inflammatory macrolide

Also Published As

Publication number Publication date
AR075340A1 (es) 2011-03-23
US20100197623A1 (en) 2010-08-05
MA32997B1 (fr) 2012-01-02
US8227428B2 (en) 2012-07-24
ZA201104653B (en) 2012-02-29
SG172782A1 (en) 2011-08-29
DOP2011000242A (es) 2011-09-15
JP2012516304A (ja) 2012-07-19
CA2748847A1 (en) 2010-08-05
CN102378763A (zh) 2012-03-14
EP2384333B1 (en) 2013-04-17
AU2010209732B2 (en) 2012-12-20
CO6400226A2 (es) 2012-03-15
WO2010086349A1 (en) 2010-08-05
CL2011001829A1 (es) 2011-10-14
ES2412059T3 (es) 2013-07-10
PE20120220A1 (es) 2012-04-04
AU2010209732A1 (en) 2011-07-21
MX2011008074A (es) 2011-08-17
TW201038277A (en) 2010-11-01
EA201101139A1 (ru) 2012-03-30
EP2384333A1 (en) 2011-11-09
KR20110099791A (ko) 2011-09-08
UY32408A (es) 2010-07-30
IL213871A0 (en) 2011-07-31
JP5437394B2 (ja) 2014-03-12

Similar Documents

Publication Publication Date Title
BRPI1014956A2 (pt) agentes antinflamatórios.
BR112012012872A2 (pt) "pirrolindinas de espiroindolinona"
BRPI0924494A2 (pt) "refrigerador."
BRPI1011414A2 (pt) "método."
BRPI1006113A2 (pt) "derivado de piridina".
FR2918218B1 (fr) Tube ondule.
BRPI0813235A2 (pt) Combinação anti-helmíntica.
BRPI1009315A2 (pt) agentes anti-inflamatórios
UY33125A (es) Diaza-espiro-[5,5]-undecanos
BRPI1010301A2 (pt) composição.
DE602008006310D1 (de) Endoskopischer Reprozessor
BRPI1013030A2 (pt) "aquecedores"
BRPI1014207A2 (pt) "trasmissão."
BRPI1016190A2 (pt) compostos farmacêuticos.
BRPI1014388A2 (pt) preparação de sólido.
IT1396487B1 (it) Convogliatore.
BRPI1016192A2 (pt) derivados de soxazol.
DK2442870T3 (da) Pyrazinooxazepin-derivater.
BRPI1008708A2 (pt) gastroscópio.
FR2941674B1 (fr) Nacelle de turboreacteur.
BRPI0816679A2 (pt) Derivados de ftalazinona.
BRPI1006114A2 (pt) "macrolídeo antiinflamatório".
FR2925545B1 (fr) Nacelle de securite
BRPI1011720A2 (pt) compostos de 1,1,1- tri-flúor-2 hidróxi-propila.
FR2946246B1 (fr) Fauteuil roulant.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]